Shire Snags EU Okay For Von Willebrand Drug Veyvondi
Executive Summary
Although noises are still being made in Japan concerning the benefits of Shire's merger with Takeda, the former is going about the business of getting marketing green lights with the latest being for its inherited bleeding disorder treatment Veyvondi in Europe.